|
 |
| Linking Research, Practice and Policy |
 |
|
|
Project Description
Coalescing on Woman and Substance Use is a project which facilitates 'virtual discussions' on six key topics related to women's substance use in Canada. Its aim is to build consensus on ways to improve services to women and to strengthen policy and research in these areas.
Each learning community works together for four months in a shared online workspace and web meetings, where participants share their expertise, experience and perspectives on women-centred substance use issues. The communities are each followed up with a web cast across Canada, to share their findings with a wider audience. Participants have joined from every province and territory, from diverse research, policy and practice fields.
The six topics for these learning communities are:
- substance use in violence/trauma support settings: integrating substance use issues support for girls and women into services for violence/trauma issues, as well as promoting integrated violence and addictions policy.
- pregnancy and substance use: integrating women-centred health approaches into prevention and policy initiatives designed to prevent Fetal Alcohol Spectrum Disorder (FASD).
- mothering: integrating women-centred and harm-reduction approaches into child protection policy and practice.
- harm reduction: integrating women-centred approaches into harm reduction settings such as needle exchanges and safe injection sites; and into drug policy and harm reduction frameworks for action.
- violence/trauma in addictions treatment settings: integrating trauma-related support tailored to girls and women, into addictions treatment settings and systemic policy guidelines/frameworks.
- emerging issue: the final topic has yet to be decided, and recommendations for topics of interest are welcome.
|
The project is sponsored by the British Columbia Centre of Excellence for Women's Health (BCCEWH) in partnership with the Canadian Women's Health Network and the Canadian Centre on Substance Abuse. The project is funded under Health Canada's Canada Drug Strategy Community Initiatives Fund. |
|
|
